Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2025-03-24 Sale |
2025-03-26 4:41 pm |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin See Remarks |
3,671 | $17.55 | $64,413 | 1,156,383 (Indirect Direct) |
View |
2025-03-17 Sale |
2025-03-20 6:27 pm |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin See Remarks |
1,200 | $17.61 | $21,137 | 1,160,054 (Indirect Direct) |
View |
2025-03-03 Sale |
2025-03-04 7:43 pm |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin See Remarks |
25,015 | $13.07 | $327,019 | 1,557,254 (Indirect Direct) |
View |
2025-02-03 Sale |
2025-02-04 8:01 pm |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin See Remarks |
19,301 | $12.7 | $245,123 | 1,035,269 (Indirect Direct) |
View |
2024-12-20 Sale |
2024-12-23 7:22 pm |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin See Remarks |
15,000 | $15.17 | $227,567 | 1,054,570 (Indirect Direct) |
View |
2024-05-31 Purchase |
2024-12-03 4:16 pm |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin See Remarks |
6,038 | $3.5194 | $21,250 | 1,069,570 (Indirect Direct) |
View |
2024-11-04 Sale |
2024-11-05 4:46 pm |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin See Remarks |
13,871 | $8.6842 | $120,459 | 1,063,532 (Indirect Direct) |
View |
2024-08-02 Sale |
2024-08-05 4:37 pm |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin See Remarks |
14,487 | $9.0183 | $130,648 | 1,077,403 (Indirect Direct) |
View |
2024-05-02 Sale |
2024-05-03 4:22 pm |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin See Remarks |
13,783 | $8.7378 | $120,433 | 1,091,890 (Indirect Direct) |
View |
2024-03-04 Sale |
2024-03-06 5:09 pm |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin See Remarks |
14,903 | $11.12 | $165,739 | 1,105,673 (Indirect Direct) |
View |
2024-02-28 Sale |
2024-03-01 4:11 pm |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin See Remarks |
2,465 | $10.6 | $26,129 | 1,120,576 (Indirect Direct) |
View |
2023-05-31 Purchase |
2023-12-01 8:51 pm |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin See Remarks |
1,463 | $6.38 | $9,334 | 782,982 (Indirect Direct) |
View |
2023-03-06 Sale |
2023-03-08 4:29 pm |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin See Remarks |
2,435 | $15.26 | $37,167 | 584,671 (Indirect Direct) |
View |
2023-02-28 Sale |
2023-03-02 7:06 pm |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin See Remarks |
7,815 | $15.93 | $124,483 | 587,106 (Indirect Direct) |
View |
2023-02-13 Sale |
2023-02-15 7:09 pm |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin See Remarks |
1,000 | $17.01 | $17,012 | 594,921 (Indirect Direct) |
View |
2023-02-01 Sale |
2023-02-03 4:26 pm |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin See Remarks |
1,000 | $17 | $17,003 | 595,921 (Indirect Direct) |
View |
2022-12-07 Sale |
2022-12-09 4:47 pm |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin See Remarks |
1,000 | $17.06 | $17,060 | 596,921 (Indirect Direct) |
View |
2022-11-07 Sale |
2022-11-09 4:39 pm |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin See Remarks |
1,000 | $18 | $18,004 | 597,921 (Indirect Direct) |
View |
2022-10-07 Sale |
2022-10-11 6:47 pm |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin President and CEO |
1,000 | $19.51 | $19,510 | 598,921 (Indirect Direct) |
View |
2022-09-07 Sale |
2022-09-09 5:10 pm |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin President and CEO |
1,000 | $21.51 | $21,510 | 599,921 (Indirect Direct) |
View |
2022-08-05 Sale |
2022-08-09 5:16 pm |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin President and CEO |
2,500 | $24.74 | $61,858 | 979,233 (Indirect Direct) |
View |
2022-07-08 Sale |
2022-07-12 7:30 pm |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin President and CEO |
13,500 | $25.37 | $342,473 | 981,733 (Indirect Direct) |
View |
2022-07-06 Sale |
2022-07-07 4:04 pm |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin President and CEO |
1,000 | $22.07 | $22,070 | 876,298 (Indirect Direct) |
View |
2022-06-06 Sale |
2022-06-06 4:06 pm |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin President and CEO |
1,000 | $21.06 | $21,064 | 877,298 (Indirect Direct) |
View |
2022-05-05 Sale |
2022-05-05 5:31 pm |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin President and CEO |
1,000 | $21.76 | $21,760 | 876,681 (Indirect Direct) |
View |
2022-04-05 Sale |
2022-04-05 6:45 pm |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin President and CEO |
1,000 | $21.43 | $21,430 | 877,681 (Indirect Direct) |
View |
2022-03-09 Sale |
2022-03-11 9:42 pm |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin President and CEO |
300 | $17 | $5,100 | 878,681 (Indirect Direct) |
View |
2022-03-04 Sale |
2022-03-07 8:59 pm |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin President and CEO |
3,259 | $16.9 | $55,088 | 1,186,016 (Indirect Direct) |
View |
2022-03-01 Sale |
2022-03-03 4:18 pm |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin President and CEO |
2,153 | $17.75 | $38,222 | 810,640 (Indirect Direct) |
View |
2022-02-09 Sale |
2022-02-11 5:55 pm |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin President and CEO |
1,000 | $17 | $17,000 | 932,428 (Indirect Direct) |
View |
2022-01-05 Sale |
2022-01-07 4:17 pm |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin President and CEO |
1,000 | $21.59 | $21,592 | 933,428 (Indirect Direct) |
View |
2021-12-08 Sale |
2021-12-10 6:41 pm |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin President and CEO |
1,000 | $17 | $17,000 | 934,428 (Indirect Direct) |
View |
2021-11-05 Sale |
2021-11-09 5:19 pm |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin President and CEO |
1,000 | $21.5 | $21,502 | 935,428 (Indirect Direct) |
View |
2021-10-05 Sale |
2021-10-07 4:05 pm |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin President and CEO |
2,500 | $24.92 | $62,294 | 936,428 (Indirect Direct) |
View |
2021-10-01 Sale |
2021-10-05 2:10 pm |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin President and CEO |
1,500 | $25.01 | $37,510 | 938,928 (Indirect Direct) |
View |
2021-09-07 Sale |
2021-09-09 5:42 pm |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin President and CEO |
1,000 | $21.14 | $21,137 | 940,428 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2025-02-28 Option Award |
2025-03-04 7:43 pm |
N/A 2035-02-28 |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin See Remarks |
547,000 | $0 | 1,557,254 (Direct) |
View |
2024-02-13 Option Award |
2024-02-15 6:30 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin See Remarks |
264,882 | $0 | 1,123,041 (Direct) |
View |
2024-01-12 Option Award |
2024-01-17 4:30 pm |
N/A 2034-01-12 |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin See Remarks |
535,000 | $0 | 1,037,019 (Direct) |
View |
2023-12-20 Gift |
2023-12-22 5:24 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin See Remarks |
6,563 | $0 | 526,432 (Direct) |
View |
2023-12-01 Exercise |
2023-12-01 8:51 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin See Remarks |
59,525 | $1.6806 | 782,982 (Direct) |
View |
2023-12-01 Exercise |
2023-12-01 8:51 pm |
N/A 2029-03-13 |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin See Remarks |
59,525 | $0 | 782,982 (Direct) |
View |
2023-03-02 Option Award(A) |
2023-03-31 9:54 pm |
N/A 2033-03-02 |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin See Remarks |
319,500 | $0 | 688,592 (Direct) |
View |
2022-06-23 Gift |
2022-09-09 5:10 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin President and CEO |
268,964 | $0 | 599,921 (Direct) |
View |
2022-08-05 Exercise |
2022-08-09 5:16 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin President and CEO |
2,500 | $1.6806 | 979,233 (Direct) |
View |
2022-08-05 Exercise |
2022-08-09 5:16 pm |
N/A 2029-03-13 |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin President and CEO |
2,500 | $0 | 979,233 (Direct) |
View |
2022-07-08 Exercise |
2022-07-12 7:30 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin President and CEO |
7,087 | $1.6806 | 981,733 (Direct) |
View |
2022-07-08 Exercise |
2022-07-12 7:30 pm |
N/A 2029-03-13 |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin President and CEO |
7,087 | $0 | 981,733 (Direct) |
View |
2022-03-03 Option Award |
2022-03-07 8:59 pm |
N/A 2032-03-03 |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin President and CEO |
259,000 | $0 | 1,186,016 (Direct) |
View |
2022-03-07 Exercise |
2022-03-07 8:59 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin President and CEO |
700 | $1.6806 | 1,186,016 (Direct) |
View |
2022-03-07 Exercise |
2022-03-07 8:59 pm |
N/A 2029-03-13 |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin President and CEO |
700 | $0 | 1,186,016 (Direct) |
View |
2022-02-09 Exercise |
2022-02-11 5:55 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin President and CEO |
1,000 | $1.6806 | 932,428 (Direct) |
View |
2022-02-09 Exercise |
2022-02-11 5:55 pm |
N/A 2029-03-13 |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin President and CEO |
1,000 | $0 | 932,428 (Direct) |
View |
2022-01-05 Exercise |
2022-01-07 4:17 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin President and CEO |
1,000 | $1.6806 | 933,428 (Direct) |
View |
2022-01-05 Exercise |
2022-01-07 4:17 pm |
N/A 2029-03-13 |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin President and CEO |
1,000 | $0 | 933,428 (Direct) |
View |
2021-12-08 Exercise |
2021-12-10 6:41 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin President and CEO |
1,000 | $1.6806 | 934,428 (Direct) |
View |
2021-12-08 Exercise |
2021-12-10 6:41 pm |
N/A 2029-03-13 |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin President and CEO |
1,000 | $0 | 934,428 (Direct) |
View |
2021-11-05 Exercise |
2021-11-09 5:19 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin President and CEO |
1,000 | $1.6806 | 935,428 (Direct) |
View |
2021-11-05 Exercise |
2021-11-09 5:19 pm |
N/A 2029-03-13 |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin President and CEO |
1,000 | $0 | 935,428 (Direct) |
View |
2021-10-05 Exercise |
2021-10-07 4:05 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin President and CEO |
2,500 | $1.6806 | 936,428 (Direct) |
View |
2021-10-05 Exercise |
2021-10-07 4:05 pm |
N/A 2029-03-13 |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin President and CEO |
2,500 | $0 | 936,428 (Direct) |
View |
2021-10-01 Exercise |
2021-10-05 2:10 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin President and CEO |
1,500 | $1.6806 | 938,928 (Direct) |
View |
2021-10-01 Exercise |
2021-10-05 2:10 pm |
N/A 2029-03-13 |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin President and CEO |
1,500 | $0 | 938,928 (Direct) |
View |
2021-09-07 Exercise |
2021-09-09 5:42 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin President and CEO |
1,000 | $1.6806 | 940,428 (Direct) |
View |
2021-09-07 Exercise |
2021-09-09 5:42 pm |
N/A 2029-03-13 |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin President and CEO |
1,000 | $0 | 940,428 (Direct) |
View |